BIRC5 and Familial prostate cancer: Continuous infusion of YM155 in athymic mice bearing PC-3 human prostate cancer xenografts caused tumor regression accompanied by increased apoptosis, decreased mitosis, and depletion of intra-tumoral Survivin, but without significant loss in body weight or overt systemic toxicity11.